US 8461187
Multiple PPI dosage form
granted A61KA61K31/4439A61K33/00
Quick answer
US patent 8461187 (Multiple PPI dosage form) held by Takeda Pharmaceuticals U.S.A., Inc. expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceuticals U.S.A., Inc.
- Grant date
- Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/4439, A61K33/00, A61K9/0004, A61P